nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—SIGMAR1—Amitriptyline—migraine	0.243	0.313	CbGbCtD
Pentazocine—OPRD1—Amitriptyline—migraine	0.208	0.267	CbGbCtD
Pentazocine—OPRK1—Amitriptyline—migraine	0.174	0.223	CbGbCtD
Pentazocine—OPRM1—Amitriptyline—migraine	0.153	0.197	CbGbCtD
Pentazocine—Diplopia—Valproic Acid—migraine	0.000924	0.00503	CcSEcCtD
Pentazocine—Loss of consciousness—Amitriptyline—migraine	0.000921	0.00502	CcSEcCtD
Pentazocine—Disorientation—Timolol—migraine	0.000919	0.00501	CcSEcCtD
Pentazocine—Euphoric mood—Gabapentin—migraine	0.000906	0.00494	CcSEcCtD
Pentazocine—Hypertension—Amitriptyline—migraine	0.000904	0.00493	CcSEcCtD
Pentazocine—Face oedema—Valproic Acid—migraine	0.000892	0.00486	CcSEcCtD
Pentazocine—Hepatic function abnormal—Gabapentin—migraine	0.000876	0.00477	CcSEcCtD
Pentazocine—Dry mouth—Amitriptyline—migraine	0.000872	0.00475	CcSEcCtD
Pentazocine—Visual impairment—Verapamil—migraine	0.000869	0.00473	CcSEcCtD
Pentazocine—Visual disturbance—Timolol—migraine	0.000868	0.00473	CcSEcCtD
Pentazocine—Confusional state—Amitriptyline—migraine	0.000862	0.0047	CcSEcCtD
Pentazocine—Disorientation—Gabapentin—migraine	0.000856	0.00466	CcSEcCtD
Pentazocine—Erythema multiforme—Verapamil—migraine	0.000852	0.00464	CcSEcCtD
Pentazocine—Shock—Amitriptyline—migraine	0.000841	0.00458	CcSEcCtD
Pentazocine—Tinnitus—Verapamil—migraine	0.00084	0.00458	CcSEcCtD
Pentazocine—Flushing—Verapamil—migraine	0.000837	0.00456	CcSEcCtD
Pentazocine—Tachycardia—Amitriptyline—migraine	0.000834	0.00455	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Valproic Acid—migraine	0.000832	0.00453	CcSEcCtD
Pentazocine—Hyperhidrosis—Amitriptyline—migraine	0.000827	0.0045	CcSEcCtD
Pentazocine—Diplopia—Timolol—migraine	0.000822	0.00448	CcSEcCtD
Pentazocine—Anorexia—Amitriptyline—migraine	0.000815	0.00444	CcSEcCtD
Pentazocine—Hypotension—Amitriptyline—migraine	0.000799	0.00435	CcSEcCtD
Pentazocine—Eosinophilia—Valproic Acid—migraine	0.000791	0.00431	CcSEcCtD
Pentazocine—Agitation—Propranolol—migraine	0.000784	0.00427	CcSEcCtD
Pentazocine—Sweating increased—Valproic Acid—migraine	0.000778	0.00424	CcSEcCtD
Pentazocine—Insomnia—Amitriptyline—migraine	0.000773	0.00421	CcSEcCtD
Pentazocine—Paraesthesia—Amitriptyline—migraine	0.000768	0.00418	CcSEcCtD
Pentazocine—Vertigo—Propranolol—migraine	0.000766	0.00418	CcSEcCtD
Pentazocine—Diplopia—Gabapentin—migraine	0.000766	0.00417	CcSEcCtD
Pentazocine—Abdominal discomfort—Valproic Acid—migraine	0.000765	0.00417	CcSEcCtD
Pentazocine—Euphoric mood—Topiramate—migraine	0.000763	0.00415	CcSEcCtD
Pentazocine—Somnolence—Amitriptyline—migraine	0.00076	0.00414	CcSEcCtD
Pentazocine—Muscle spasms—Verapamil—migraine	0.000754	0.00411	CcSEcCtD
Pentazocine—Decreased appetite—Amitriptyline—migraine	0.000743	0.00405	CcSEcCtD
Pentazocine—Vision blurred—Verapamil—migraine	0.000739	0.00403	CcSEcCtD
Pentazocine—Face oedema—Gabapentin—migraine	0.000739	0.00403	CcSEcCtD
Pentazocine—Tremor—Verapamil—migraine	0.000735	0.00401	CcSEcCtD
Pentazocine—Constipation—Amitriptyline—migraine	0.000731	0.00398	CcSEcCtD
Pentazocine—Irritability—Gabapentin—migraine	0.000731	0.00398	CcSEcCtD
Pentazocine—Urinary retention—Gabapentin—migraine	0.000728	0.00397	CcSEcCtD
Pentazocine—Agitation—Verapamil—migraine	0.000721	0.00393	CcSEcCtD
Pentazocine—Disorientation—Topiramate—migraine	0.00072	0.00392	CcSEcCtD
Pentazocine—Vertigo—Verapamil—migraine	0.000705	0.00384	CcSEcCtD
Pentazocine—Feeling abnormal—Amitriptyline—migraine	0.000705	0.00384	CcSEcCtD
Pentazocine—Syncope—Verapamil—migraine	0.000704	0.00383	CcSEcCtD
Pentazocine—Anaphylactic shock—Propranolol—migraine	0.000696	0.00379	CcSEcCtD
Pentazocine—Loss of consciousness—Verapamil—migraine	0.00069	0.00376	CcSEcCtD
Pentazocine—Sweating—Valproic Acid—migraine	0.000682	0.00372	CcSEcCtD
Pentazocine—Visual disturbance—Topiramate—migraine	0.00068	0.0037	CcSEcCtD
Pentazocine—Hypertension—Verapamil—migraine	0.000677	0.00369	CcSEcCtD
Pentazocine—Agranulocytosis—Valproic Acid—migraine	0.000664	0.00362	CcSEcCtD
Pentazocine—Eosinophilia—Gabapentin—migraine	0.000655	0.00357	CcSEcCtD
Pentazocine—Dry mouth—Verapamil—migraine	0.000653	0.00356	CcSEcCtD
Pentazocine—Confusional state—Verapamil—migraine	0.000646	0.00352	CcSEcCtD
Pentazocine—Sweating increased—Gabapentin—migraine	0.000645	0.00351	CcSEcCtD
Pentazocine—Diplopia—Topiramate—migraine	0.000644	0.00351	CcSEcCtD
Pentazocine—Anaphylactic shock—Verapamil—migraine	0.00064	0.00349	CcSEcCtD
Pentazocine—Hallucination—Valproic Acid—migraine	0.000636	0.00346	CcSEcCtD
Pentazocine—Shock—Verapamil—migraine	0.00063	0.00343	CcSEcCtD
Pentazocine—Insomnia—Propranolol—migraine	0.00063	0.00343	CcSEcCtD
Pentazocine—Paraesthesia—Propranolol—migraine	0.000625	0.00341	CcSEcCtD
Pentazocine—Tachycardia—Verapamil—migraine	0.000625	0.00341	CcSEcCtD
Pentazocine—Face oedema—Topiramate—migraine	0.000622	0.00339	CcSEcCtD
Pentazocine—Dyspnoea—Propranolol—migraine	0.000621	0.00338	CcSEcCtD
Pentazocine—Hyperhidrosis—Verapamil—migraine	0.000619	0.00337	CcSEcCtD
Pentazocine—Somnolence—Propranolol—migraine	0.000619	0.00337	CcSEcCtD
Pentazocine—Visual impairment—Valproic Acid—migraine	0.000616	0.00336	CcSEcCtD
Pentazocine—Irritability—Topiramate—migraine	0.000615	0.00335	CcSEcCtD
Pentazocine—Asthenia—Amitriptyline—migraine	0.000613	0.00334	CcSEcCtD
Pentazocine—Urinary retention—Topiramate—migraine	0.000613	0.00334	CcSEcCtD
Pentazocine—Sweating—Timolol—migraine	0.000608	0.00331	CcSEcCtD
Pentazocine—Decreased appetite—Propranolol—migraine	0.000605	0.0033	CcSEcCtD
Pentazocine—Pruritus—Amitriptyline—migraine	0.000605	0.0033	CcSEcCtD
Pentazocine—Erythema multiforme—Valproic Acid—migraine	0.000604	0.00329	CcSEcCtD
Pentazocine—Hypotension—Verapamil—migraine	0.000598	0.00326	CcSEcCtD
Pentazocine—Tinnitus—Valproic Acid—migraine	0.000596	0.00325	CcSEcCtD
Pentazocine—Constipation—Propranolol—migraine	0.000595	0.00324	CcSEcCtD
Pentazocine—Agranulocytosis—Timolol—migraine	0.000591	0.00322	CcSEcCtD
Pentazocine—Diarrhoea—Amitriptyline—migraine	0.000585	0.00319	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Topiramate—migraine	0.00058	0.00316	CcSEcCtD
Pentazocine—Insomnia—Verapamil—migraine	0.000579	0.00316	CcSEcCtD
Pentazocine—Paraesthesia—Verapamil—migraine	0.000575	0.00313	CcSEcCtD
Pentazocine—Chills—Valproic Acid—migraine	0.000573	0.00312	CcSEcCtD
Pentazocine—Dyspnoea—Verapamil—migraine	0.000571	0.00311	CcSEcCtD
Pentazocine—Somnolence—Verapamil—migraine	0.000569	0.0031	CcSEcCtD
Pentazocine—Hallucination—Timolol—migraine	0.000566	0.00308	CcSEcCtD
Pentazocine—Sweating—Gabapentin—migraine	0.000566	0.00308	CcSEcCtD
Pentazocine—Dizziness—Amitriptyline—migraine	0.000565	0.00308	CcSEcCtD
Pentazocine—Eosinophilia—Topiramate—migraine	0.000551	0.003	CcSEcCtD
Pentazocine—Visual impairment—Timolol—migraine	0.000548	0.00299	CcSEcCtD
Pentazocine—Constipation—Verapamil—migraine	0.000548	0.00298	CcSEcCtD
Pentazocine—Dysgeusia—Valproic Acid—migraine	0.000545	0.00297	CcSEcCtD
Pentazocine—Vomiting—Amitriptyline—migraine	0.000544	0.00296	CcSEcCtD
Pentazocine—Sweating increased—Topiramate—migraine	0.000542	0.00296	CcSEcCtD
Pentazocine—Dermatitis—Amitriptyline—migraine	0.000539	0.00293	CcSEcCtD
Pentazocine—Headache—Amitriptyline—migraine	0.000536	0.00292	CcSEcCtD
Pentazocine—Muscle spasms—Valproic Acid—migraine	0.000535	0.00291	CcSEcCtD
Pentazocine—Abdominal discomfort—Topiramate—migraine	0.000534	0.00291	CcSEcCtD
Pentazocine—Tinnitus—Timolol—migraine	0.00053	0.00289	CcSEcCtD
Pentazocine—Feeling abnormal—Verapamil—migraine	0.000528	0.00288	CcSEcCtD
Pentazocine—Hallucination—Gabapentin—migraine	0.000527	0.00287	CcSEcCtD
Pentazocine—Vision blurred—Valproic Acid—migraine	0.000524	0.00286	CcSEcCtD
Pentazocine—Tremor—Valproic Acid—migraine	0.000521	0.00284	CcSEcCtD
Pentazocine—Hypersensitivity—Propranolol—migraine	0.000513	0.00279	CcSEcCtD
Pentazocine—Agitation—Valproic Acid—migraine	0.000511	0.00279	CcSEcCtD
Pentazocine—Visual impairment—Gabapentin—migraine	0.000511	0.00278	CcSEcCtD
Pentazocine—Nausea—Amitriptyline—migraine	0.000508	0.00277	CcSEcCtD
Pentazocine—Erythema multiforme—Gabapentin—migraine	0.000501	0.00273	CcSEcCtD
Pentazocine—Vertigo—Valproic Acid—migraine	0.0005	0.00272	CcSEcCtD
Pentazocine—Asthenia—Propranolol—migraine	0.000499	0.00272	CcSEcCtD
Pentazocine—Tinnitus—Gabapentin—migraine	0.000494	0.00269	CcSEcCtD
Pentazocine—OPRM1—Peptide GPCRs—EDNRA—migraine	0.000489	0.0124	CbGpPWpGaD
Pentazocine—Dysgeusia—Timolol—migraine	0.000485	0.00264	CcSEcCtD
Pentazocine—Hypertension—Valproic Acid—migraine	0.00048	0.00262	CcSEcCtD
Pentazocine—OPRD1—G alpha (i) signalling events—HTR1D—migraine	0.000478	0.0122	CbGpPWpGaD
Pentazocine—Diarrhoea—Propranolol—migraine	0.000476	0.0026	CcSEcCtD
Pentazocine—Chills—Gabapentin—migraine	0.000475	0.00259	CcSEcCtD
Pentazocine—Hypersensitivity—Verapamil—migraine	0.000472	0.00257	CcSEcCtD
Pentazocine—Vision blurred—Timolol—migraine	0.000467	0.00254	CcSEcCtD
Pentazocine—Agranulocytosis—Topiramate—migraine	0.000463	0.00252	CcSEcCtD
Pentazocine—Dry mouth—Valproic Acid—migraine	0.000463	0.00252	CcSEcCtD
Pentazocine—Dizziness—Propranolol—migraine	0.00046	0.00251	CcSEcCtD
Pentazocine—Asthenia—Verapamil—migraine	0.000459	0.0025	CcSEcCtD
Pentazocine—Confusional state—Valproic Acid—migraine	0.000458	0.00249	CcSEcCtD
Pentazocine—Anaphylactic shock—Valproic Acid—migraine	0.000454	0.00247	CcSEcCtD
Pentazocine—Pruritus—Verapamil—migraine	0.000453	0.00247	CcSEcCtD
Pentazocine—Dysgeusia—Gabapentin—migraine	0.000452	0.00246	CcSEcCtD
Pentazocine—Vertigo—Timolol—migraine	0.000445	0.00242	CcSEcCtD
Pentazocine—Syncope—Timolol—migraine	0.000444	0.00242	CcSEcCtD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000443	0.0113	CbGpPWpGaD
Pentazocine—Hallucination—Topiramate—migraine	0.000443	0.00242	CcSEcCtD
Pentazocine—Muscle spasms—Gabapentin—migraine	0.000443	0.00242	CcSEcCtD
Pentazocine—Tachycardia—Valproic Acid—migraine	0.000443	0.00241	CcSEcCtD
Pentazocine—Vomiting—Propranolol—migraine	0.000443	0.00241	CcSEcCtD
Pentazocine—Hyperhidrosis—Valproic Acid—migraine	0.000439	0.00239	CcSEcCtD
Pentazocine—Dermatitis—Propranolol—migraine	0.000439	0.00239	CcSEcCtD
Pentazocine—Diarrhoea—Verapamil—migraine	0.000438	0.00239	CcSEcCtD
Pentazocine—Loss of consciousness—Timolol—migraine	0.000435	0.00237	CcSEcCtD
Pentazocine—Vision blurred—Gabapentin—migraine	0.000435	0.00237	CcSEcCtD
Pentazocine—Anorexia—Valproic Acid—migraine	0.000433	0.00236	CcSEcCtD
Pentazocine—Tremor—Gabapentin—migraine	0.000432	0.00235	CcSEcCtD
Pentazocine—Visual impairment—Topiramate—migraine	0.00043	0.00234	CcSEcCtD
Pentazocine—Hypertension—Timolol—migraine	0.000428	0.00233	CcSEcCtD
Pentazocine—Hypotension—Valproic Acid—migraine	0.000424	0.00231	CcSEcCtD
Pentazocine—Agitation—Gabapentin—migraine	0.000424	0.00231	CcSEcCtD
Pentazocine—Dizziness—Verapamil—migraine	0.000423	0.00231	CcSEcCtD
Pentazocine—Erythema multiforme—Topiramate—migraine	0.000421	0.0023	CcSEcCtD
Pentazocine—OPRK1—G alpha (i) signalling events—HTR1D—migraine	0.000419	0.0107	CbGpPWpGaD
Pentazocine—Tinnitus—Topiramate—migraine	0.000416	0.00226	CcSEcCtD
Pentazocine—Vertigo—Gabapentin—migraine	0.000414	0.00226	CcSEcCtD
Pentazocine—Flushing—Topiramate—migraine	0.000414	0.00225	CcSEcCtD
Pentazocine—Syncope—Gabapentin—migraine	0.000414	0.00225	CcSEcCtD
Pentazocine—Nausea—Propranolol—migraine	0.000413	0.00225	CcSEcCtD
Pentazocine—Dry mouth—Timolol—migraine	0.000412	0.00225	CcSEcCtD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000412	0.0105	CbGpPWpGaD
Pentazocine—Insomnia—Valproic Acid—migraine	0.000411	0.00224	CcSEcCtD
Pentazocine—Paraesthesia—Valproic Acid—migraine	0.000408	0.00222	CcSEcCtD
Pentazocine—Confusional state—Timolol—migraine	0.000408	0.00222	CcSEcCtD
Pentazocine—Vomiting—Verapamil—migraine	0.000407	0.00222	CcSEcCtD
Pentazocine—Loss of consciousness—Gabapentin—migraine	0.000405	0.00221	CcSEcCtD
Pentazocine—Dyspnoea—Valproic Acid—migraine	0.000405	0.00221	CcSEcCtD
Pentazocine—Anaphylactic shock—Timolol—migraine	0.000404	0.0022	CcSEcCtD
Pentazocine—Somnolence—Valproic Acid—migraine	0.000404	0.0022	CcSEcCtD
Pentazocine—Dermatitis—Verapamil—migraine	0.000403	0.0022	CcSEcCtD
Pentazocine—Headache—Verapamil—migraine	0.000401	0.00219	CcSEcCtD
Pentazocine—Chills—Topiramate—migraine	0.0004	0.00218	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—CALCRL—migraine	0.000398	0.0101	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—RAMP1—migraine	0.000398	0.0101	CbGpPWpGaD
Pentazocine—Hypertension—Gabapentin—migraine	0.000398	0.00217	CcSEcCtD
Pentazocine—Shock—Timolol—migraine	0.000398	0.00217	CcSEcCtD
Pentazocine—Decreased appetite—Valproic Acid—migraine	0.000395	0.00215	CcSEcCtD
Pentazocine—Hyperhidrosis—Timolol—migraine	0.000391	0.00213	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000389	0.0099	CbGpPWpGaD
Pentazocine—Constipation—Valproic Acid—migraine	0.000388	0.00212	CcSEcCtD
Pentazocine—Anorexia—Timolol—migraine	0.000385	0.0021	CcSEcCtD
Pentazocine—Dry mouth—Gabapentin—migraine	0.000384	0.00209	CcSEcCtD
Pentazocine—Nausea—Verapamil—migraine	0.00038	0.00207	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00038	0.00967	CbGpPWpGaD
Pentazocine—Dysgeusia—Topiramate—migraine	0.00038	0.00207	CcSEcCtD
Pentazocine—Confusional state—Gabapentin—migraine	0.00038	0.00207	CcSEcCtD
Pentazocine—Hypotension—Timolol—migraine	0.000378	0.00206	CcSEcCtD
Pentazocine—Anaphylactic shock—Gabapentin—migraine	0.000376	0.00205	CcSEcCtD
Pentazocine—Feeling abnormal—Valproic Acid—migraine	0.000374	0.00204	CcSEcCtD
Pentazocine—Muscle spasms—Topiramate—migraine	0.000373	0.00203	CcSEcCtD
Pentazocine—Shock—Gabapentin—migraine	0.00037	0.00202	CcSEcCtD
Pentazocine—Tachycardia—Gabapentin—migraine	0.000367	0.002	CcSEcCtD
Pentazocine—Vision blurred—Topiramate—migraine	0.000366	0.00199	CcSEcCtD
Pentazocine—Insomnia—Timolol—migraine	0.000366	0.00199	CcSEcCtD
Pentazocine—Hyperhidrosis—Gabapentin—migraine	0.000364	0.00198	CcSEcCtD
Pentazocine—Tremor—Topiramate—migraine	0.000364	0.00198	CcSEcCtD
Pentazocine—Paraesthesia—Timolol—migraine	0.000363	0.00198	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000362	0.0092	CbGpPWpGaD
Pentazocine—Dyspnoea—Timolol—migraine	0.00036	0.00196	CcSEcCtD
Pentazocine—Somnolence—Timolol—migraine	0.000359	0.00196	CcSEcCtD
Pentazocine—Anorexia—Gabapentin—migraine	0.000359	0.00195	CcSEcCtD
Pentazocine—Agitation—Topiramate—migraine	0.000357	0.00194	CcSEcCtD
Pentazocine—OPRM1—G alpha (i) signalling events—HTR1D—migraine	0.000354	0.00901	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000353	0.00899	CbGpPWpGaD
Pentazocine—Hypotension—Gabapentin—migraine	0.000352	0.00192	CcSEcCtD
Pentazocine—Decreased appetite—Timolol—migraine	0.000351	0.00191	CcSEcCtD
Pentazocine—OPRK1—GPCR ligand binding—CALCRL—migraine	0.000349	0.00889	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—RAMP1—migraine	0.000349	0.00889	CbGpPWpGaD
Pentazocine—Vertigo—Topiramate—migraine	0.000349	0.0019	CcSEcCtD
Pentazocine—Syncope—Topiramate—migraine	0.000348	0.0019	CcSEcCtD
Pentazocine—Loss of consciousness—Topiramate—migraine	0.000341	0.00186	CcSEcCtD
Pentazocine—Insomnia—Gabapentin—migraine	0.00034	0.00185	CcSEcCtD
Pentazocine—Paraesthesia—Gabapentin—migraine	0.000338	0.00184	CcSEcCtD
Pentazocine—Dyspnoea—Gabapentin—migraine	0.000336	0.00183	CcSEcCtD
Pentazocine—Hypertension—Topiramate—migraine	0.000335	0.00183	CcSEcCtD
Pentazocine—Somnolence—Gabapentin—migraine	0.000335	0.00182	CcSEcCtD
Pentazocine—Hypersensitivity—Valproic Acid—migraine	0.000335	0.00182	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000333	0.00848	CbGpPWpGaD
Pentazocine—Feeling abnormal—Timolol—migraine	0.000333	0.00181	CcSEcCtD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000329	0.00837	CbGpPWpGaD
Pentazocine—Decreased appetite—Gabapentin—migraine	0.000327	0.00178	CcSEcCtD
Pentazocine—Asthenia—Valproic Acid—migraine	0.000326	0.00177	CcSEcCtD
Pentazocine—OPRD1—Peptide ligand-binding receptors—NPS—migraine	0.000325	0.00828	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—TAC1—migraine	0.000325	0.00828	CbGpPWpGaD
Pentazocine—Dry mouth—Topiramate—migraine	0.000323	0.00176	CcSEcCtD
Pentazocine—Constipation—Gabapentin—migraine	0.000322	0.00175	CcSEcCtD
Pentazocine—Pruritus—Valproic Acid—migraine	0.000321	0.00175	CcSEcCtD
Pentazocine—Confusional state—Topiramate—migraine	0.000319	0.00174	CcSEcCtD
Pentazocine—Shock—Topiramate—migraine	0.000312	0.0017	CcSEcCtD
Pentazocine—Diarrhoea—Valproic Acid—migraine	0.000311	0.00169	CcSEcCtD
Pentazocine—OPRD1—Peptide ligand-binding receptors—EDNRA—migraine	0.00031	0.0079	CbGpPWpGaD
Pentazocine—Feeling abnormal—Gabapentin—migraine	0.00031	0.00169	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00031	0.00788	CbGpPWpGaD
Pentazocine—Tachycardia—Topiramate—migraine	0.000309	0.00168	CcSEcCtD
Pentazocine—Hyperhidrosis—Topiramate—migraine	0.000306	0.00167	CcSEcCtD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000306	0.00778	CbGpPWpGaD
Pentazocine—Anorexia—Topiramate—migraine	0.000302	0.00164	CcSEcCtD
Pentazocine—Dizziness—Valproic Acid—migraine	0.0003	0.00164	CcSEcCtD
Pentazocine—Hypersensitivity—Timolol—migraine	0.000298	0.00162	CcSEcCtD
Pentazocine—Hypotension—Topiramate—migraine	0.000296	0.00161	CcSEcCtD
Pentazocine—OPRM1—GPCR ligand binding—CALCRL—migraine	0.000295	0.00751	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—RAMP1—migraine	0.000295	0.00751	CbGpPWpGaD
Pentazocine—Asthenia—Timolol—migraine	0.00029	0.00158	CcSEcCtD
Pentazocine—OPRD1—G alpha (i) signalling events—HTR1B—migraine	0.00029	0.00737	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HTR1D—migraine	0.000289	0.00737	CbGpPWpGaD
Pentazocine—Vomiting—Valproic Acid—migraine	0.000289	0.00157	CcSEcCtD
Pentazocine—Insomnia—Topiramate—migraine	0.000286	0.00156	CcSEcCtD
Pentazocine—Dermatitis—Valproic Acid—migraine	0.000286	0.00156	CcSEcCtD
Pentazocine—Pruritus—Timolol—migraine	0.000286	0.00156	CcSEcCtD
Pentazocine—OPRK1—Peptide ligand-binding receptors—TAC1—migraine	0.000285	0.00726	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—NPS—migraine	0.000285	0.00726	CbGpPWpGaD
Pentazocine—Headache—Valproic Acid—migraine	0.000284	0.00155	CcSEcCtD
Pentazocine—Paraesthesia—Topiramate—migraine	0.000284	0.00155	CcSEcCtD
Pentazocine—Dyspnoea—Topiramate—migraine	0.000282	0.00154	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000282	0.00717	CbGpPWpGaD
Pentazocine—Somnolence—Topiramate—migraine	0.000282	0.00153	CcSEcCtD
Pentazocine—EBP—Metabolism—CACNA1A—migraine	0.00028	0.00713	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—HTR1A—migraine	0.000279	0.00709	CbGpPWpGaD
Pentazocine—Hypersensitivity—Gabapentin—migraine	0.000277	0.00151	CcSEcCtD
Pentazocine—Diarrhoea—Timolol—migraine	0.000277	0.00151	CcSEcCtD
Pentazocine—Decreased appetite—Topiramate—migraine	0.000275	0.0015	CcSEcCtD
Pentazocine—OPRK1—Peptide ligand-binding receptors—EDNRA—migraine	0.000272	0.00693	CbGpPWpGaD
Pentazocine—Constipation—Topiramate—migraine	0.000271	0.00148	CcSEcCtD
Pentazocine—Asthenia—Gabapentin—migraine	0.00027	0.00147	CcSEcCtD
Pentazocine—Nausea—Valproic Acid—migraine	0.00027	0.00147	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—HTR2B—migraine	0.000269	0.00685	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000269	0.00684	CbGpPWpGaD
Pentazocine—Dizziness—Timolol—migraine	0.000267	0.00146	CcSEcCtD
Pentazocine—Pruritus—Gabapentin—migraine	0.000266	0.00145	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000262	0.00666	CbGpPWpGaD
Pentazocine—Feeling abnormal—Topiramate—migraine	0.000261	0.00142	CcSEcCtD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000259	0.00658	CbGpPWpGaD
Pentazocine—Diarrhoea—Gabapentin—migraine	0.000258	0.0014	CcSEcCtD
Pentazocine—Vomiting—Timolol—migraine	0.000257	0.0014	CcSEcCtD
Pentazocine—Dermatitis—Timolol—migraine	0.000255	0.00139	CcSEcCtD
Pentazocine—OPRK1—G alpha (i) signalling events—HTR1B—migraine	0.000254	0.00646	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HTR1D—migraine	0.000254	0.00646	CbGpPWpGaD
Pentazocine—Headache—Timolol—migraine	0.000253	0.00138	CcSEcCtD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00025	0.00636	CbGpPWpGaD
Pentazocine—Dizziness—Gabapentin—migraine	0.000249	0.00136	CcSEcCtD
Pentazocine—OPRK1—G alpha (i) signalling events—HTR1A—migraine	0.000244	0.00622	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000243	0.00619	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—NPS—migraine	0.000241	0.00614	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—TAC1—migraine	0.000241	0.00614	CbGpPWpGaD
Pentazocine—Nausea—Timolol—migraine	0.00024	0.00131	CcSEcCtD
Pentazocine—Vomiting—Gabapentin—migraine	0.000239	0.0013	CcSEcCtD
Pentazocine—Dermatitis—Gabapentin—migraine	0.000237	0.00129	CcSEcCtD
Pentazocine—OPRK1—GPCR ligand binding—HTR2B—migraine	0.000236	0.006	CbGpPWpGaD
Pentazocine—Headache—Gabapentin—migraine	0.000236	0.00128	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000236	0.006	CbGpPWpGaD
Pentazocine—Hypersensitivity—Topiramate—migraine	0.000233	0.00127	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00023	0.00586	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—EDNRA—migraine	0.00023	0.00585	CbGpPWpGaD
Pentazocine—Asthenia—Topiramate—migraine	0.000227	0.00124	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000227	0.00577	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—RAMP1—migraine	0.000225	0.00573	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CALCRL—migraine	0.000225	0.00573	CbGpPWpGaD
Pentazocine—Pruritus—Topiramate—migraine	0.000224	0.00122	CcSEcCtD
Pentazocine—Nausea—Gabapentin—migraine	0.000224	0.00122	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000222	0.00564	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000219	0.00558	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000219	0.00557	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000218	0.00555	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000218	0.00555	CbGpPWpGaD
Pentazocine—Diarrhoea—Topiramate—migraine	0.000217	0.00118	CcSEcCtD
Pentazocine—OPRM1—G alpha (i) signalling events—HTR1B—migraine	0.000215	0.00546	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR1D—migraine	0.000214	0.00546	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000214	0.00545	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000213	0.00542	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—FOS—migraine	0.000211	0.00537	CbGpPWpGaD
Pentazocine—Dizziness—Topiramate—migraine	0.000209	0.00114	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000208	0.0053	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—HTR1A—migraine	0.000207	0.00526	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—RAMP1—migraine	0.000204	0.0052	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CALCRL—migraine	0.000204	0.0052	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000202	0.00514	CbGpPWpGaD
Pentazocine—Vomiting—Topiramate—migraine	0.000201	0.0011	CcSEcCtD
Pentazocine—Dermatitis—Topiramate—migraine	0.000199	0.00109	CcSEcCtD
Pentazocine—OPRM1—GPCR ligand binding—HTR2B—migraine	0.000199	0.00507	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000199	0.00507	CbGpPWpGaD
Pentazocine—Headache—Topiramate—migraine	0.000198	0.00108	CcSEcCtD
Pentazocine—OPRK1—GPCR downstream signaling—RAMP1—migraine	0.000197	0.00502	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CALCRL—migraine	0.000197	0.00502	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000194	0.00495	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000192	0.00488	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000192	0.00488	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000191	0.00487	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000191	0.00487	CbGpPWpGaD
Pentazocine—Nausea—Topiramate—migraine	0.000188	0.00102	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000188	0.00478	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000187	0.00477	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000185	0.00471	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000183	0.00465	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00018	0.00458	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RAMP1—migraine	0.000179	0.00456	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CALCRL—migraine	0.000179	0.00456	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HTR1B—migraine	0.000175	0.00446	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000171	0.00434	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HTR1A—migraine	0.000169	0.0043	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CALCRL—migraine	0.000167	0.00425	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—RAMP1—migraine	0.000167	0.00425	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—TAC1—migraine	0.000166	0.00423	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—NPS—migraine	0.000166	0.00423	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000164	0.00418	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000164	0.00418	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR1D—migraine	0.000164	0.00416	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HTR2C—migraine	0.000163	0.00415	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000162	0.00413	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000162	0.00412	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000162	0.00412	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000159	0.00404	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—EDNRA—migraine	0.000159	0.00404	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000154	0.00393	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HTR1B—migraine	0.000154	0.00391	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000153	0.0039	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CALCA—migraine	0.000153	0.00388	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR2B—migraine	0.000152	0.00387	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RAMP1—migraine	0.000151	0.00386	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CALCRL—migraine	0.000151	0.00386	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR1D—migraine	0.000148	0.00378	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HTR1A—migraine	0.000148	0.00377	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—NPS—migraine	0.000146	0.00371	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—TAC1—migraine	0.000146	0.00371	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR1D—migraine	0.000143	0.00365	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HTR2C—migraine	0.000143	0.00364	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HTR7—migraine	0.000143	0.00363	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—EDNRA—migraine	0.000139	0.00354	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000139	0.00354	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR2B—migraine	0.000138	0.00351	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000134	0.00342	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CALCA—migraine	0.000134	0.00341	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR2B—migraine	0.000133	0.00339	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000131	0.00334	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR1D—migraine	0.00013	0.00331	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR1B—migraine	0.00013	0.00331	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HTR7—migraine	0.000125	0.00319	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR1A—migraine	0.000125	0.00318	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—TAC1—migraine	0.000123	0.00313	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—NPS—migraine	0.000123	0.00313	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR1D—migraine	0.000121	0.00308	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR2B—migraine	0.000121	0.00308	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR2C—migraine	0.000121	0.00307	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CALCRL—migraine	0.000121	0.00307	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RAMP1—migraine	0.000121	0.00307	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—EDNRA—migraine	0.000117	0.00299	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000115	0.00293	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000114	0.00289	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CALCA—migraine	0.000113	0.00288	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR2B—migraine	0.000113	0.00287	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR1D—migraine	0.00011	0.0028	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CALCRL—migraine	0.000106	0.00269	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RAMP1—migraine	0.000106	0.00269	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR7—migraine	0.000106	0.00269	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2B—migraine	0.000102	0.0026	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HTR2A—migraine	0.0001	0.00254	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR1B—migraine	9.91e-05	0.00252	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.73e-05	0.00248	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR1A—migraine	9.54e-05	0.00243	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—NPS—migraine	9.39e-05	0.00239	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—TAC1—migraine	9.39e-05	0.00239	CbGpPWpGaD
Pentazocine—EBP—Metabolism—MTHFR—migraine	9.27e-05	0.00236	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR2C—migraine	9.21e-05	0.00234	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR1B—migraine	9e-05	0.00229	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—EDNRA—migraine	8.96e-05	0.00228	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CALCRL—migraine	8.95e-05	0.00228	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RAMP1—migraine	8.95e-05	0.00228	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR1D—migraine	8.77e-05	0.00223	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HTR2A—migraine	8.77e-05	0.00223	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR1B—migraine	8.69e-05	0.00221	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR1A—migraine	8.66e-05	0.0022	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CALCA—migraine	8.62e-05	0.0022	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TAC1—migraine	8.53e-05	0.00217	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—NPS—migraine	8.53e-05	0.00217	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR2C—migraine	8.36e-05	0.00213	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR1A—migraine	8.36e-05	0.00213	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—TAC1—migraine	8.24e-05	0.0021	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—NPS—migraine	8.24e-05	0.0021	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2B—migraine	8.15e-05	0.00208	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EDNRA—migraine	8.14e-05	0.00207	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR2C—migraine	8.08e-05	0.00206	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR7—migraine	8.07e-05	0.00205	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR1B—migraine	7.89e-05	0.00201	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—EDNRA—migraine	7.86e-05	0.002	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CALCA—migraine	7.83e-05	0.00199	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR1D—migraine	7.69e-05	0.00196	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR1A—migraine	7.59e-05	0.00193	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CALCA—migraine	7.56e-05	0.00192	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TAC1—migraine	7.48e-05	0.0019	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NPS—migraine	7.48e-05	0.0019	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR2A—migraine	7.41e-05	0.00189	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR1B—migraine	7.34e-05	0.00187	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR2C—migraine	7.33e-05	0.00187	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR7—migraine	7.33e-05	0.00186	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LRP1—migraine	7.18e-05	0.00183	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2B—migraine	7.15e-05	0.00182	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EDNRA—migraine	7.13e-05	0.00182	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR7—migraine	7.07e-05	0.0018	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR1A—migraine	7.07e-05	0.0018	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—TAC1—migraine	6.96e-05	0.00177	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—NPS—migraine	6.96e-05	0.00177	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CALCA—migraine	6.87e-05	0.00175	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR2C—migraine	6.83e-05	0.00174	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR1B—migraine	6.67e-05	0.0017	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—EDNRA—migraine	6.64e-05	0.00169	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR1D—migraine	6.5e-05	0.00165	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR7—migraine	6.42e-05	0.00164	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR1A—migraine	6.42e-05	0.00163	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CALCA—migraine	6.39e-05	0.00163	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NPS—migraine	6.32e-05	0.00161	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TAC1—migraine	6.32e-05	0.00161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LRP1—migraine	6.3e-05	0.0016	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2C—migraine	6.2e-05	0.00158	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2B—migraine	6.04e-05	0.00154	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EDNRA—migraine	6.03e-05	0.00153	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR7—migraine	5.98e-05	0.00152	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CALCA—migraine	5.8e-05	0.00148	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR2A—migraine	5.65e-05	0.00144	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH4—migraine	5.51e-05	0.0014	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR7—migraine	5.43e-05	0.00138	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LRP1—migraine	5.32e-05	0.00135	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR1B—migraine	5.31e-05	0.00135	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR2A—migraine	5.13e-05	0.00131	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR1A—migraine	5.12e-05	0.0013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TAC1—migraine	5.04e-05	0.00128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NPS—migraine	5.04e-05	0.00128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PGR—migraine	5.04e-05	0.00128	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR2A—migraine	4.95e-05	0.00126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2C—migraine	4.94e-05	0.00126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH4—migraine	4.83e-05	0.00123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EDNRA—migraine	4.81e-05	0.00122	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH3—migraine	4.68e-05	0.00119	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR1B—migraine	4.66e-05	0.00119	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CALCA—migraine	4.63e-05	0.00118	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR2A—migraine	4.5e-05	0.00115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR1A—migraine	4.49e-05	0.00114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PGR—migraine	4.42e-05	0.00112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NPS—migraine	4.42e-05	0.00112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TAC1—migraine	4.42e-05	0.00112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2C—migraine	4.33e-05	0.0011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR7—migraine	4.33e-05	0.0011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EDNRA—migraine	4.21e-05	0.00107	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR2A—migraine	4.19e-05	0.00107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH3—migraine	4.11e-05	0.00105	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH4—migraine	4.08e-05	0.00104	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CALCA—migraine	4.06e-05	0.00103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR1B—migraine	3.94e-05	0.001	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2A—migraine	3.8e-05	0.000968	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR7—migraine	3.79e-05	0.000966	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR1A—migraine	3.79e-05	0.000965	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PGR—migraine	3.73e-05	0.00095	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPS—migraine	3.73e-05	0.00095	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TAC1—migraine	3.73e-05	0.00095	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFBR2—migraine	3.73e-05	0.000949	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2C—migraine	3.66e-05	0.000932	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDNRA—migraine	3.56e-05	0.000907	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH3—migraine	3.47e-05	0.000884	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CALCA—migraine	3.43e-05	0.000873	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFBR2—migraine	3.27e-05	0.000832	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR7—migraine	3.21e-05	0.000816	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2A—migraine	3.03e-05	0.000771	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFBR2—migraine	2.76e-05	0.000703	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ESR1—migraine	2.69e-05	0.000685	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2A—migraine	2.66e-05	0.000676	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ESR1—migraine	2.36e-05	0.0006	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2A—migraine	2.25e-05	0.000572	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ESR1—migraine	1.99e-05	0.000507	CbGpPWpGaD
